1-3
2026
影响因子区间
—
平台估算
14%
2025
中国作者发文占比
USD 3,290
收费
期刊简介:ASSAY and Drug Development Technologies provides access to novel techniques and robust tools that enable critical advances in early-stage screening. This research published in the Journal leads to important therapeutics and platforms for drug discovery and development. This reputable peer-reviewed journal features original papers application-oriented technology reviews, topical issues on novel and burgeoning areas of research, and reports in methodology and technology application.ASSAY and Drug Development Technologies coverage includes:-Assay design, target development, and high-throughput technologies-Hit to Lead optimization and medicinal chemistry through preclinical candidate selection-Lab automation, sample management, bioinformatics, data mining, virtual screening, and data analysis-Approaches to assays configured for gene families, inherited, and infectious diseases-Assays and strategies for adapting model organisms to drug discovery-The use of stem cells as models of disease-Translation of phenotypic outputs to target identification-Exploration and mechanistic studies of the technical basis for assay and screening artifacts
【译文】提供新颖技术和强大工具,以实现早期筛选的关键进展。该研究发表在期刊上,导致重要的治疗药物和药物发现与开发平台。这本备受推崇的同行评审期刊特色包括:应用导向的技术综述、关于新颖和新兴研究领域的专题问题,以及方法和技术应用方面的报告。

| 指标 | 当前值 | 近三年趋势 |
|---|---|---|
| JCR分区 | Q3 | 暂无 |
| 中科院分区 | 4区 | 暂无 |
| 影响因子区间 | 1-3 | 暂无 |